Gamida Cell to delist as Highbridge takes full ownership
Israeli stem cell therapy firm Gamida Cell (Nasdaq: GMDA) has introduced that Highbridge Capital Administration, the corporate's principal lender, ...
Tag: Gamida
Israeli stem cell therapy firm Gamida Cell (Nasdaq: GMDA) has introduced that Highbridge Capital Administration, the corporate's principal lender, ...